Research analysts at StockNews.com began coverage on shares of China Pharma (NYSE:CPHI – Get Free Report) in a research report issued to clients and investors on Monday. The brokerage set a “hold” rating on the stock.
China Pharma Stock Up 0.8 %
Shares of China Pharma stock opened at $0.25 on Monday. The company’s fifty day simple moving average is $0.22 and its two-hundred day simple moving average is $0.26. China Pharma has a 12-month low of $0.17 and a 12-month high of $1.16. The company has a debt-to-equity ratio of 0.19, a current ratio of 0.84 and a quick ratio of 0.24.
China Pharma (NYSE:CPHI – Get Free Report) last announced its earnings results on Wednesday, August 14th. The company reported ($0.09) earnings per share for the quarter. The company had revenue of $0.93 million for the quarter. China Pharma had a negative net margin of 70.47% and a negative return on equity of 60.19%.
About China Pharma
China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.
Further Reading
- Five stocks we like better than China Pharma
- What is Short Interest? How to Use It
- Is Spotify Stock Poised to Soar? Options Traders Think So
- What Are Some of the Best Large-Cap Stocks to Buy?
- Misses and Beats: 3 Stocks That Are Moving Markets Right Now
- What is the Euro STOXX 50 Index?
- Cisco on the Rise: AI Potential and Analyst Upgrades Drive Gains
Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
